80145 Drug assay adalimumab
Pathology & Lab
Also known as: adalimumab level, Humira level
Laboratory quantitative drug assay for adalimumab (Humira) to assess serum level and therapeutic drug monitoring in rheumatologic disease treatment.
Clinical Context
Monitors therapeutic levels of tumor necrosis factor-alpha inhibitor therapy for optimal efficacy in rheumatoid arthritis, inflammatory bowel disease, and other conditions.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.